Vaxart Inc (NASDAQ:VXRT)

5.29
Delayed Data
As of 3:03pm ET
 +0.10 / +1.93%
Today’s Change
4.74
Today|||52-Week Range
11.88
-15.08%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$20.4M

Company Description

Vaxart, Inc. is engaged in the development of vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.

Contact Information

Vaxart, Inc.
290 Utah Avenue
South San Francisco California 94080
P:(650) 550-3500
Investor Relations:

Employees

Shareholders

Other institutional8.55%
Mutual fund holders2.37%
Individual stakeholders1.15%

Top Executives

Wouter W. LatourPresident, Chief Executive Officer & Director
John M. HarlandChief Financial Officer
David Neal LiebowitzChief Medical Officer
Sean N. TuckerChief Scientific Officer
Brant BiehnSenior Vice President-Commercial Operations